 |
市場調査レポート
商品コード
980824
医薬品開発業務受託機関（CRO）世界市場：サービス（臨床調査、前臨床、実験室サービスなど）、治療領域、エンドユーザー、地域別 - 2027年までの予測Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology], Laboratory Services, and others), Therapeutic Area, End, and Geography - Global Forecast to 2027 |
||||||
| 医薬品開発業務受託機関（CRO）世界市場：サービス（臨床調査、前臨床、実験室サービスなど）、治療領域、エンドユーザー、地域別 - 2027年までの予測 |
|
出版日: 2021年01月06日
発行: Meticulous Market Research Pvt. Ltd.
ページ情報: 英文 240 Pages
納期: 即納可能
 |
世界の医薬品開発業務受託機関（CRO）の市場規模は、2020年から2027年までの間に6.5％のCAGRで成長し、2027年には644億米ドルに達すると予測されています。同市場の主な成長要因には、バイオ医薬品の需要の高まり、臨床試験件数の増加、バイオ医薬品製造に対する政府の支援の高まりなどが挙げられます。
さらに、新興市場からの機会、バイオシミラーの需要増加、バイオシミラー技術の継続的な進歩により、同市場で活動する企業への大きな機会の提供が見込まれています。ただし、COVID-19パンデミックは、2019年から2020年の間、同市場の成長に悪影響を及ぼしました。
当レポートは、世界の医薬品開発業務受託機関（CRO）市場について調査しており、市場の機会や課題、成長および抑制要因、Covid-19の影響、サービス・治療領域・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。
The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report includes key industry drivers, restraints, challenges, and opportunities. The growth in the contract research organizations market is mainly attributed to the rising demand for biopharmaceuticals, an increasing number of clinical trials, and growing government support for biopharmaceutical manufacturing. Moreover, opportunities from emerging markets, increasing demand for biosimilars, and continuous advancements in bioprocessing techniques offer significant opportunities for players operating in the contract research organizations market. However, the recent outbreak of COVID-19 has adversely affected the growth of the CROs market during 2019-2020.
Based on service, the clinical research services segment accounted for the largest share of this market in 2019. The large share of this segment is mainly attributed to an increase in the number of clinical trials globally, growth in outsourcing of clinical trials, especially Phase III and Phase II trials, and growth in collaborations between key players and clinical service providers to reduce failures.
Based on therapeutic area, the oncology segment is estimated to account for the largest share of this market in 2020. The large share of this segment is mainly attributed to an increase in the number of oncology clinical trials globally, growth in government investments for the development of personalized medicines for oncology, and high demand for biosimilars for cancer.
Moreover, based on end user, the pharmaceutical & biotechnology companies segment is estimated to account for the largest share of the global contract research organizations market in 2020. An increase in R&D investments for drug development, growing collaborations of pharmaceutical companies with CROs to conduct clinical trials, and government initiatives to support the growth of pharmaceutical companies are the key factors driving the growth of the contract research organizations market for pharmaceutical & biotechnology companies.
An in-depth geographic analysis of the contract research organization market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America commanded the largest share of the global contract research organizations market in 2019, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa.
The key players operating in the global contract research organizations market are IQVIA Holdings Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Charles River Laboratories International, Inc. (U.S.), Wuxi Apptec Co., Ltd. (China), Medpace Holdings, Inc. (U.S.), PRA Health Sciences, Inc. (U.S.), Syneos Health, Inc. (U.S.), PARAXEL International Corporation (U.S.), Envigo RMS LLC (U.S.), ICON plc (Ireland), PPD, Inc. (U.S.), and SGS S.A. (Switzerland).
Global Contract Research Organizations Market, by Service
(Note: Other pre-clinical services include biocompatibility testing, study design, development plans, documentation of protocols, authoring of pre-clinical reports, regulatory submissions, and others)
(Note: Other analytical testing services include method development, validation, residual testing, environmental monitoring, and microbial detection services)
Global Contract Research Organizations Market, by Application
(Note: Other therapeutic areas include hepatology, gastroenterology, ophthalmology, gastroenterology, respiratory diseases, dermatology, and muscular disorders)
Global Contract Research Organization Market, by End User
Global Contract Research Organizations Market, by Geography
比較リスト
